Max Robotics — Global Service Robot Directory + US Certification

About

Catherine Williamson is a leading figure in maternal-fetal medicine, renowned for her groundbreaking work on intrahepatic cholestasis of pregnancy (ICP) and the genetic underpinnings of pregnancy-related liver disorders. Her research has fundamentally advanced understanding of how genetic variation contributes to ICP susceptibility, particularly through her comprehensive analysis of common variants around six candidate loci, including the ABCB11 gene. This seminal 2013 study, cited over 120 times, demonstrated that heterozygous mutations in canalicular transporters and population susceptibility alleles play a critical role in ICP etiology. Beyond genetics, Williamson has made major contributions to elucidating the pathophysiology of obstetric cholestasis, bile acid metabolism, and placental function, directly informing clinical management strategies that improve maternal and fetal outcomes. Her work has garnered widespread recognition, with her most cited papers collectively shaping international guidelines for ICP diagnosis and treatment. A professor at King’s College London, she has mentored numerous researchers and continues to drive translational research bridging genetic discovery and clinical care in high-risk pregnancies.